Recovery Discovery | Beyond Opioids: How AI-Designed Cannabinoids Could Change Addiction Recovery

Can the endocannabinoid system (ECS) help reshape the future of pain treatment and addiction recovery?

In this episode of Recovery Discovery, DeAnn and Craig explore the science behind the body’s endocannabinoid system, a powerful biological network responsible for maintaining balance, pain regulation, inflammation control, and emotional wellbeing.

Their guest, Caitlin Krebs, co-founder and CEO of Nalu Bio, explains how researchers are using artificial intelligence and advanced drug discovery technology to design non-addictive cannabinoid-based medicines that target the ECS without intoxication or dependency.

The conversation explores how AI-engineered compounds could potentially provide pain relief comparable to opioids without the addiction risk, opening new possibilities for people in recovery who often struggle with limited medical options for pain management.

If you have questions or comments or would like to be a guest on the Recovery Discovery Podcast, send an email to:
[e-mail]

More information about our project is available at:
https://www.showupandstay.org/
https://www.soberpositiveworkplace.org/

For podcast updates, follow us on Instagram:
https://www.instagram.com/showupandstayorg/

Music and Audio Production by Katie Hare.
https://www.hare.works